Subscribe to My Feed
Loading ...Brazil Producing Generic Version of Tamiflu
Sunday, August 2nd, 2009Synopsis in English: Brazil’s Pharmaceutical Technology Institute (commonly known by its old name, Farmanguinhos), a subsidiary of the state-run public health entity Oswaldo Cruz Foundation (“Fiocruz“), has started producing capsules of oseltamivir phosphate, the generic version of the marketed by pharma multinational Roche as Tamiflu, for distribution by the Health Ministry (MS) to reference hospitals […]
Fiocruz Gets Green Light to Produce AIDS Medicine Under Compulsory License
Wednesday, January 28th, 2009Brazil’s National Sanitary Vigilance Agency (ANVISA) has authorized the Pharmaceutical Technology Institute (“Farmanguinhos“) of the Oswaldo Cruz Foundation (“Fiocruz“) to begin producing the antiretriviral drug Efavirenz. About 80,000 Brazilian HIV-positive patients currently receive the drug through the National Program on Sexually-Transmitted Diseases (STDs) and AIDS. To refresh memories, Efavirenz is the AIDS drug for which […]
Brazil Proceeds with Compulsory Licensing of Antiretroviral Drug / Brasil continua com a licença compulsória de medicamento antiretroviral
Monday, October 6th, 2008Temas Observation: All developing nations have had the clear right to resort to compulsory licensing of pharmaceuticals since the adoption of the Doha Declaration by the World Trade Organization (WTO) in 2001. Brazil has long reserved this right under its own laws, although previously it has been hesitant to actually use the power, preferring instead […]
A Dengue Vaccine by December?
Tuesday, August 26th, 2008During the 60th Annual Meeting of the Brazilian Society for the Advancement of Science (Sociedade Brasileira para o Progresso da Ciência– SBPC) last month held in Campinas, São Paulo, it was announced that Brazil probably will go to market first with a vaccine against dengue and that they may start producing it as early as […]